Back to Studies

IMPAACT 2022

Phase II Study of the Virologic Efficacy and Feasibility of Long-Acting Injectable Antiretroviral Medications in Non-Adherent Youth with HIV

Study Status

In Development

DAIDS Number

38631

Primary Protocol Team Members

Allison Agwu Study Co-Chair

Ethel Weld Study Co-Chair

Adeola Adeyeye DAIDS Medical Officer

Ellen Townley DAIDS Medical Officer

Bill Kapogiannis NICHD Medical Officer

Loading study documents...

Loading study sites...

Loading study protocol team...

Loading study press...

Loading study publications/presentations...